Pierluigi Antonelli
Corporate Officer/Principal en FRESENIUS SE & CO. KGAA .
Perfil
Pierluigi Antonelli is currently the Chief Executive Officer-Fresenius Kabi at Fresenius SE & Co. KGaA. He is also the President & Chief Executive Officer at Fresenius Kabi AG and the Chief Executive Officer at Fresenius Kabi.
Previously, he held the position of Chief Executive Officer at Aziende Chimiche.
Riunite Angelini Francesco - A.C.R.A.F.
- SpA and Angelini Pharma, Inc. From 2019 to 2023, he served as the Chief Executive Officer at Angelini Pharma SpA. He was also the European Vice President & Managing Director-Italy at Bristol-Myers Squibb GmbH & Co. KGaA and the Head-Europe Novartis Oncology at Sandoz Deutschland GmbH from 2015 to 2019.
Prior to that, he worked as an Engagement Manager at Mckinsey & Co., Inc. (Munich) from 1994 to 1998 and as a Senior Vice President-Italy at Merck & Co. Mr. Antonelli holds an MBA from Northwestern University, which he obtained in 1994.
He also completed his undergraduate studies at The LUISS University of Rome in 1989.
Últimas noticias acerca de Pierluigi Antonelli
Cargos activos de Pierluigi Antonelli
Empresas | Cargo | Inicio |
---|---|---|
FRESENIUS SE & CO. KGAA | Corporate Officer/Principal | 01/03/2023 |
Fresenius Kabi AG
![]() Fresenius Kabi AG Pharmaceuticals: MajorHealth Technology Fresenius Kabi AG manufactures medical devices for therapies. It specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. The firm offers infusion solutions for fluid substitution, blood volume replacement, intravenously administered drugs as well as the respective medical devices for the application, pump systems and infusion management systems. The company was founded in 1999 and is headquartered in Bad Homburg, Germany. | Director Ejecutivo | - |
Fresenius Kabi | Director Ejecutivo | - |
Antiguos cargos conocidos de Pierluigi Antonelli.
Empresas | Cargo | Fin |
---|---|---|
Angelini Pharma SpA
![]() Angelini Pharma SpA Miscellaneous Commercial ServicesCommercial Services Angelini Pharma SpA is an Italian pharmaceutical company that focuses on researching and developing medicines and pharmaceutical products. The private company is based in Rome, Italy. The company was founded in 1919. Jacopo Andreose has been the CEO of the company since 2023. | Director Ejecutivo | 06/02/2023 |
Sandoz Deutschland GmbH
![]() Sandoz Deutschland GmbH Financial ConglomeratesFinance Part of Novartis AG, Novartis Deutschland GmbH is an investment holding German company. The company is based in Nuremberg, Germany. | Corporate Officer/Principal | 01/01/2019 |
Mckinsey & Co., Inc. (Munich) | Corporate Officer/Principal | 01/01/1998 |
Bristol-Myers Squibb GmbH & Co. KGaA
![]() Bristol-Myers Squibb GmbH & Co. KGaA Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb GmbH & Co. KGaA is a German company that manufactures biopharmaceutical medicines. The company is based in Munich, Germany. The company was founded in 1887. The CEO is Remo Gujer. | Corporate Officer/Principal | - |
Merck & Co. | Corporate Officer/Principal | - |
Formación de Pierluigi Antonelli.
Northwestern University | Masters Business Admin |
The LUISS University of Rome | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
FRESENIUS SE & CO. KGAA | Health Services |
Empresas privadas | 9 |
---|---|
Angelini Pharma, Inc.
![]() Angelini Pharma, Inc. Specialty StoresRetail Trade Angelini Pharma, Inc. operates as a medical supply store. The company is headquartered in Rockville, MD. | Retail Trade |
Aziende Chimiche Riunite Angelini Francesco - A.C.R.A.F. - SpA
![]() Aziende Chimiche Riunite Angelini Francesco - A.C.R.A.F. - SpA Pharmaceuticals: OtherHealth Technology Aziende Chimiche Riunite Angelini Francesco - A.C.R.A.F. - SpA engages in the design, marketing, and distribution of pharmaceuticals for health and wellness. It specializes in developing therapies for pain and inflammatory disorders, diseases and disorders of the nervous system, infection control, and infectious diseases. The company was founded by Francesco Angelini in 1941 and is headquartered in Rome, Italy. | Health Technology |
Angelini Pharma SpA
![]() Angelini Pharma SpA Miscellaneous Commercial ServicesCommercial Services Angelini Pharma SpA is an Italian pharmaceutical company that focuses on researching and developing medicines and pharmaceutical products. The private company is based in Rome, Italy. The company was founded in 1919. Jacopo Andreose has been the CEO of the company since 2023. | Commercial Services |
Sandoz Deutschland GmbH
![]() Sandoz Deutschland GmbH Financial ConglomeratesFinance Part of Novartis AG, Novartis Deutschland GmbH is an investment holding German company. The company is based in Nuremberg, Germany. | Finance |
Merck & Co. | Finance |
Bristol-Myers Squibb GmbH & Co. KGaA
![]() Bristol-Myers Squibb GmbH & Co. KGaA Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb GmbH & Co. KGaA is a German company that manufactures biopharmaceutical medicines. The company is based in Munich, Germany. The company was founded in 1887. The CEO is Remo Gujer. | Health Technology |
Mckinsey & Co., Inc. (Munich) | |
Fresenius Kabi AG
![]() Fresenius Kabi AG Pharmaceuticals: MajorHealth Technology Fresenius Kabi AG manufactures medical devices for therapies. It specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. The firm offers infusion solutions for fluid substitution, blood volume replacement, intravenously administered drugs as well as the respective medical devices for the application, pump systems and infusion management systems. The company was founded in 1999 and is headquartered in Bad Homburg, Germany. | Health Technology |
Fresenius Kabi |
- Bolsa de valores
- Insiders
- Pierluigi Antonelli